KOPRAN
|
The Current P/B Ratio of KOPRAN is 1.56.
Share Price | ₹167.4 | Oct 16,2025 |
Market Cap | ₹808.3 Cr | |
Book Value | ₹516.7 Cr | Mar2025 - Consolidated Results |
Price/Book | 1.56x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹808.3 Cr] as on Oct 16,2025
(/) Book Value [ ₹516.7 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 1.56x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.56 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.09x.
- KOPRAN 's operated at median p/b ratio of 1.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2023 of 1.21x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
KOPRAN | 516.73 | 1.56 | 808.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.51 | 398,218.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.70 | 175,158.0 |
CIPLA LTD | 31,079.30 | 4.08 | 126,710.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.75 | 119,586.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.10 | 103,496.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.09 | 101,320.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.13 | 99,013.4 |
LUPIN LTD | 17,119.50 | 5.20 | 89,093.5 |
AUROBINDO PHARMA LTD | 32,653.30 | 1.97 | 64,222.1 |
ABBOTT INDIA LTD | 4,204.27 | 15.08 | 63,398.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.56x |
Max industry PB | 15.75x |
Median industry PB | 5.20x |
Average industry PB | 6.83x |
You may also like the below Video Courses